The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A population-based study of BRCA breast cancer incidence and prognosis in the Italian Emilia Romagna region: The MUTina study.
 
Laura Cortesi
Honoraria - AstraZeneca; Gilead Sciences; MSD; Novartis; Pfizer
Consulting or Advisory Role - MSD; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Gilead Sciences; MSD Oncology; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences
 
Marta Venturelli
No Relationships to Disclose
 
Angela Toss
Honoraria - Lilly; Pfizer
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; MSD/AstraZeneca; Novartis
Travel, Accommodations, Expenses - Lilly; Novartis
 
Elena Barbieri
Honoraria - Istituto Gentili
Travel, Accommodations, Expenses - Lilly; Novartis Italy
 
Antonino Musolino
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Eisai Europe; Lilly; Seagen
Research Funding - Lilly; Roche (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Ugo De Giorgi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dompé Farmaceutici; Eisai; Ipsen; Janssen; Merck KGaA; MSD; Novartis; Pfizer; PharmaMar
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Giancarlo Bisagni
No Relationships to Disclose
 
Valentina Arcangeli
No Relationships to Disclose
 
Claudio Zamagni
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daichi-Sankyo; EISAI; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Lilly; MSD Oncology; Novartis; Pfizer; PharmaMar; Roche; Seagen
Research Funding - Abbvie (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Medivation (Inst); Morphotek (Inst); Novartis (Inst); pfizer (Inst); Roche (Inst); Roche/Genentech (Inst); Seagen (Inst); Synthon (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daichi-Sankyo; Gilead Sciences; Novartis; Pfizer; Roche
 
Luigi Cavanna
Consulting or Advisory Role - AstraZeneca; Merck
Travel, Accommodations, Expenses - Celgene; Ipsen; Pfizer
 
Massimo Dominici
Leadership - Evotec
Consulting or Advisory Role - Evotec
Research Funding - Chiesi; Rigenerand